| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.8 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |